Search results
Results from the WOW.Com Content Network
5-HT 2C receptor agonists are a class of drugs that activate 5-HT 2C receptors. They have been investigated for the treatment of a number of conditions including obesity , psychiatric disorders , sexual dysfunction and urinary incontinence .
This is a list of miscellaneous agonists of the serotonin receptor subtype 5-HT 2A (and other 5-HT 2 subtypes to a varying extent) that fall outside the common structural classes.
The 5-HT 1B receptor as an example of a metabotropic serotonin receptor. Its crystallographic structure in ribbon representation. 5-HT receptors, 5-hydroxytryptamine receptors, or serotonin receptors, are a group of G protein-coupled receptor and ligand-gated ion channels found in the central and peripheral nervous systems.
However, with the discovery that the 5-HT 3 receptor plays a prominent role in chemotherapy- and radiotherapy-induced vomiting, and the concomitant development of selective 5-HT 3 receptor antagonists to suppress these side effects aroused intense interest from the pharmaceutical industry [2] [33] and therefore the identification of 5-HT 3 ...
Vilazodone is a 5-HT 1A receptor partial agonist while vortioxetine is a 5-HT 1A receptor agonist and 5-HT 3 and 5-HT 7 receptor antagonist. [206] Litoxetine (SL 81–0385) and lubazodone (YM-992, YM-35995) are similar drugs that were never marketed.
The 5HT 6 receptor is a subtype of 5HT receptor that binds the endogenous neurotransmitter serotonin (5-hydroxytryptamine, 5HT). [5] It is a G protein-coupled receptor (GPCR) that is coupled to G s and mediates excitatory neurotransmission . [ 5 ]
Noradrenergic and specific serotonergic antidepressants (NaSSAs) are a class of psychiatric drugs used primarily as antidepressants. [1] They act by antagonizing the α 2 -adrenergic receptor and certain serotonin receptors such as 5-HT 2A and 5-HT 2C , [ 1 ] but also 5-HT 3 , [ 1 ] 5-HT 6 , and/or 5-HT 7 in some cases.
5-Hydroxytryptamine (serotonin) receptor 5A, also known as HTR5A, is a protein that in humans is encoded by the HTR5A gene. [5] [6] Agonists and antagonists for 5-HT receptors, as well as serotonin uptake inhibitors, present promnesic (memory-promoting) and/or anti-amnesic effects under different conditions, and 5-HT receptors are also associated with neural changes.